Reduced LDHB expression via promoter hypermethylation has been observed in prostate, breast, and pancreatic cancers, and greater LDHB suppression is associated with metastatic progression, particularly in hypoxia [18,26]. This evidence concerns the gene LDHB and familial pancreatic carcinoma.